⚠This browser is out of date. ⚠ To ensure this website functions properly, please upgrade your browser or use a different one.
Chordoma
Immunotherapy clinical trial halts growth of Doug's rare sarcoma
Doug White, right, celebrates his 100th immunotherapy infusion with Dr. Howard Bailey in September. White started the treatment in 2016 as part of a clinical trial to treat a rare sarcoma called chordoma.